Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-11

Clinical Trial Update: Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on the use of chronic ACE inhibitors in intermediate-risk surgery, with completed status and results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Hypotension on Induction | Phase 4 | Status: COMPLETED | Results posted: 2017-12-11